Showing results (31-40 of 204) with videos related to
Sort By:
Pageof 21
Clinical Advances in Hematology & Oncology : H&O|April 9, 2016
Options for Second-Line Treatment in Metastatic Colorectal CancerJames J Lee, Weijing SunNature Clinical Practice. Oncology|December 19, 2008
Which questions remain unanswered following the successful development of sorafenib in hepatocellular carcinoma?Keith T Flaherty, Weijing SunCancer Biology & Therapy|April 4, 2003
Recent advances in colorectal cancer therapyTracy S d'Entremont, Weijing SunClinical Colorectal Cancer|September 2, 2006
Oxaliplatin-associated hypersensitivity reactions: clinical presentation and managementMaureen R Hewitt, Weijing SunCurrent Opinion in Gastroenterology|January 28, 2021
Immunotherapy in cholangiocarcinomaRaed Al-Rajabi, Weijing SunThe Oncologist|October 13, 2009
Resection of the primary colorectal cancer is not necessary in nonobstructed patients with metastatic diseaseNevena Damjanov, Jared Weiss, Daniel G HallerCancer|January 26, 2011
Phase 2 trial of bevacizumab, capecitabine, and oxaliplatin in treatment of advanced hepatocellular carcinomaWeijing Sun, Davendra Sohal, Daniel G Haller, et al.Current Oncology Reports|March 17, 2011
Hepatocellular carcinoma: prevention and therapyDavendra P S Sohal, Weijing SunJournal of Hematology & Oncology|January 13, 2021
The integration of immune checkpoint inhibitors with VEGF targeted agents in advanced gastric and gastroesophageal adenocarcinoma: a review on the rationale and results of early phase trialsAnwaar Saeed, Robin Park, Weijing SunExpert Review of Anticancer Therapy|November 26, 2011
What is the reference cytotoxic regimen for advanced gastric cancer: standard versus optimal therapy?Davendra P S Sohal, Weijing SunPageof 21